to adjustment upon the occurrence of certain events. The initial conversion price of the Notes represents a premium of approximately 37.5% over the last reported sale price of the common stock on the New York Stock Exchange on April 23, 2019. The Notes will be convertible only upon the occurrence of certain events and during certain periods. The Notes will bear interest at a rate of 2.00% per year, payable semi-annually in arrears on April 15 and October 15 of each year, beginning on October 15, 2019. The Notes will mature on April 15, 2024, unless earlier repurchased or converted in accordance with their terms.
Expected Use of Proceeds of the Offering of Notes
Share Repurchases
After effectuating the convertible note hedge transactions described below, the Company intends to use substantially all of the remaining net proceeds from the Notes offering to repurchase shares of its common stock pursuant to its previously announced $500 million share repurchase program.
Concurrently with the pricing of the Notes, the Company repurchased $26 million of its common stock from purchasers of the Notes in privately negotiated transactions through the initial purchaser or its affiliates, as the Company’s agent, for settlement concurrently with the closing of the Notes offering. The purchase price per share of the common stock repurchased in such transactions equaled the closing sale price of the Company’s common stock on April 23, 2019, which was $18.75 per share.
The Company intends to repurchase approximately $24 million of common stock in open-market purchases at prevailing market rates promptly following the pricing of the Notes. The Company may use the offering proceeds to offset cash on hand spent on such repurchases.
Shortly following the closing of the Notes offering, the Company intends to repurchase $170 million or more of its common stock through the accelerated share repurchase program (the “ASR”). The Company expects to enter into the ASR with one or more financial institutions (in such capacity, the “ASR counterparty”) shortly following the closing of the Notes offering.
The Company intends to use the remaining net proceeds from the offering of the Notes, if any, for additional share repurchases and general corporate purposes, including, but not limited to, repayment of indebtedness and for working capital, provided that the Company has not designated any specific uses and has no current agreements or commitments with respect to any material acquisition or strategic transaction. Pending any specific application, the Company may invest the remaining net proceeds from the offering of the Notes in short- and long-term marketable securities.
In connection with the ASR, the Company has been advised that the ASR counterparty expects to purchase shares of the Company’s common stock in secondary market transactions and/or execute other transactions in the Company’s common stock, or in derivative transactions relating to the Company’s common stock, during the term of the ASR.
The purchase price per share of the common stock repurchased through the ASR will generally be equal to the average volume-weighted average price of the Company’s common stock during the term of the ASR. The exact number of shares repurchased pursuant to the ASR will be determined based on such purchase price. Any such share repurchases may increase, or prevent a decrease in, the market price of the Company’s common stock or the Notes.
Concurrent Transactions
The Company also expects to use approximately $30 million of the net proceeds from the offering of the Notes to pay the cost of the convertible note hedge transactions described below (after such cost is partially offset by the proceeds from the sale of warrants pursuant to the warrant transactions described below). If the initial purchaser exercises its over-allotment option, then the Company intends to use a portion of the additional net proceeds to fund the cost of entering into additional convertible note hedge transactions (after such cost is partially offset by the proceeds that the Company receives from entering into the additional warrant transactions described below).
Other Matters
These activities and the Company’s repurchases of shares of its common stock may cause or avoid an increase or a decrease in the market price of the Company’s common stock or the Notes, which could affect the ability of holders to convert the Notes, and, to the extent the activity occurs during any observation period related to a conversion of Notes, it could affect the amount and value of the consideration that the holders will receive upon conversion of the Notes.